Efficacy of Azacitidine (AZA) in Autoimmune and Inflammatory Disorders (AID) Associated with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) - Université de Rennes Access content directly
Journal Articles Blood Year : 2015

Efficacy of Azacitidine (AZA) in Autoimmune and Inflammatory Disorders (AID) Associated with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Abstract

57th Annual Meeting of the American-Society-of-Hematology Location: Orlando, FL Date: DEC 05-08, 2015
No file

Dates and versions

hal-01300814 , version 1 (11-04-2016)

Identifiers

  • HAL Id : hal-01300814 , version 1

Cite

Jean-Baptiste Fraison, Arsène Mekinian, Eric Grignano, Jean-Emmanuel Kahn, Jean-Benoît Arlet, et al.. Efficacy of Azacitidine (AZA) in Autoimmune and Inflammatory Disorders (AID) Associated with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML). Blood, 2015, 126 (23), pp.1695. ⟨hal-01300814⟩
79 View
0 Download

Share

Gmail Facebook X LinkedIn More